Concepedia

Alec B. Wilkens

AB

Statistics

Publications

4

Citations

2.1K

H-Index

4

Active since

2015

Affiliations

Fred Hutch Cancer Center(Current)

University of Washington

Stanford University

Alec B. Wilkens is an author at Fred Hutch Cancer Center specializing in life sciences, crispr-cas9 genome editing, and crispr-cas systems.

ORCID

Publications per year

2015–2024

4

Publications

4

Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells

Ayal Hendel, Rasmus O. Bak, Joseph T. Clark et al. · Nature Biotechnology · 2015 · 1.1K citations · Full text

, , +12

CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells

Daniel P. Dever, Rasmus O. Bak, Andreas Reinisch et al. · Nature · 2016 · 876 citations · Full text

, , +14

TIM-3 <sup>+</sup> CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies

Simone A. Minnie, Olivia G. Waltner, Ping Zhang et al. · Science Immunology · 2024 · 47 citations · Full text

, , +17

NOTCH1 signaling during CD4+ T-cell activation alters transcription factor networks and enhances antigen responsiveness

Alec B. Wilkens, Elena C. Fulton, Margot J. Pont et al. · Blood · 2022 · 26 citations · Full text

, , +15

1–4 of 4